EGFR路径的改变与质母细胞瘤的快速早期进展相关
Kayla Samimi1, Aren Singh Saini1, Kaylie Cullison1
1Department of Radiation Oncology, Sylvester Comprehensive Cancer Center, University of Miami Miller School of Medicine, Miami, USA.
Journal of neuro-oncology
|November 10, 2025
概括
质母细胞瘤的快速早期进展 (REP) 与EGFR变化有关. 在手术后识别这些分子变化可以帮助确定辅助治疗的紧迫性,以防止瘤生长.
科学领域:
- 神经瘤学神经瘤学
- 分子诊断学 分子诊断学
- 瘤成像学成像学
背景情况:
- 快速早期进展 (REP) 影响大约50%的质母细胞瘤患者手术后,与较差的生存率相关.
- 质母细胞瘤的分子表征正在进步,但其与REP的联系仍未得到充分研究.
- 及时的辅助治疗对于质母细胞瘤管理至关重要.
研究的目的:
- 研究质母细胞瘤中的分子变化与快速早期进展 (REP) 之间的关联.
- 识别可预测REP的分子标记物,并可告知辅助治疗时间.
- 在质母细胞瘤患者中分析特定基因突变,MGMT甲基化和REP之间的相关性.
主要方法:
- 对100名经过切除的质母细胞瘤患者的回顾性分析,随后进行下一代测序和放射治疗.
- 在术后和RT计划扫描之间,REP被定义为切除腔边界的MRI增强.
- 下一代测序分析了TERT促进体,EGFR,PTEN,TP53,CDKN2A/2B,NF1,MTAP,PIK3CA的变化,以及MGMT甲基化状态.
主要成果:
- 在45%的患者中观察到REP.
- 单变量分析显示了REP和EGFR变化 (p=0.001) 和MGMT甲基化 (p=0.016) 之间的显著关联.
- 多变量分析证实了EGFR变化是REP的唯一显著预测因子 (p=0.006).
结论:
- EGFR变化是快速早期质母细胞瘤进展的重要预测因素.
- 术后确定EGFR变异可能需要加快辅助治疗.
- 需要进行进一步的研究,以优化EGFR变异和REP的质母细胞瘤患者的治疗策略.
相关概念视频
mTOR Signaling and Cancer Progression
4.6K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
4.6K
Mitogens and the Cell Cycle
7.7K
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
7.7K
Tumor Progression
7.2K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
7.2K
The Retinoblastoma Gene
4.6K
Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
4.6K
Interactions Between Signaling Pathways
7.2K
Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
7.2K


